Since isolated PC cultured on decellularized matrices from fibrotic lungs adopt expression of α-SMA and the administration of an inhibitor of lung fibrosis restores the elastic component of these fibrotic matrices by reverting the α-SMA LP phenotype, this opens a new field of study and reveals targets for pulmonary fibrosis treatment. This evidence concerns the gene ACTA1 and pulmonary fibrosis.